Eculizumab Intravenous and Novoeight recombinant
Determining the interaction of Eculizumab Intravenous and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: eculizumab
Brand name: Soliris
Synonyms: Eculizumab
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eculizumab Intravenous-Novolin 70/30
- Eculizumab Intravenous-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Eculizumab Intravenous-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Eculizumab Intravenous-Novolin N
- Eculizumab Intravenous-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Eculizumab Intravenous-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Ed A-Hist
- Novoeight recombinant-Ed A-Hist DM
- Novoeight recombinant-Ed ChlorPed
- Novoeight recombinant-Ed ChlorPed D
- Novoeight recombinant-Ed Cyte F
- Novoeight recombinant-Ed-Chlor Ped Jr